(A) Each pediatric respite care program shall arrange for provision of medical supplies, appliances, drugs, and biologicals to pediatric respite patients as needed for the palliation and management of the patient's life-threatening disease or condition and related conditions. The program shall ensure that drugs and biologicals are available at all times.
(B) The pediatric respite care patient or pediatric respite care patient's family may provide the pediatric respite care program with the patient's current medical supplies, drugs, biologicals, and medical appliances for administration and use while the patient is enrolled in the pediatric respite care program.
(C) Each pediatric respite care program shall ensure that drugs and biologicals are administered only by the following individuals:
(1) A physician, registered nurse, or a licensed practical nurse;
(2) A patient or a family member if approved by the attending physician; or
(3) Any other individual authorized by the Revised Code to perform this task.
(D) The individuals authorized to administer drugs or biologicals under paragraphs (B)(2) and (B)(3) of this rule and the drugs or biologicals they are authorized to administer shall be specified in the patient's plan of care.
(E) Each pediatric respite care program shall have a written policy for disposing of controlled drugs maintained by the facility for the pediatric respite care patient while the patient is enrolled in the pediatric respite care program when those drugs no longer are needed by the patient.
(F) Each pediatric respite care program shall ensure that the patient, patient's representative, and the patient's family receive a copy of the pediatric respite care program's written policies and procedures along with education on the management and disposal of controlled drugs when a controlled substance is ordered, and document such actions in the patient's clinical record.